An immune defect that may set Crohn's disease in motion

What To Know

New University of Toronto-led lab research published in Nature Immunology reports that defects in the NOD2 gene reduced recruitment of T cells to gut lymph nodes and impaired T cell responses to infection in animal models.

The authors propose that NOD2-related weakened early immunity—combined with increased intestinal permeability—could allow small infections to persist and later trigger excessive inflammation seen in Crohn’s disease. The lab confirmed findings using an additional Listeria infection model and is exploring approaches to restore NOD2-related function.

This article summarizes a basic-science study using animal models and experimental tracking of T cells; it does not report results from clinical trials or direct patient interventions. It presents a hypothesis for disease initiation (weakened initial immunity leading to secondary inflammation) that challenges more common inflammation-first views.

If you follow IBD research, this paper points to immune-pathway and host–microbe interactions (NOD2, T cell recruitment, barrier permeability) as potential early drivers of Crohn’s-like disease in genetically susceptible models.

The team is pursuing strategies to compensate for reduced NOD2 function, but clinical relevance and therapies remain to be established.